• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经动脉化疗栓塞术治疗的原发性肝癌患者分期系统的预后准确性

Prognostic accuracy of staging systems in patients with primary liver cancer undergoing transarterial chemoembolization.

作者信息

Zhuge Yuzheng, Zhang Feng, Qiu Yudong, Li Zhenlei, Zhang Jianwu

机构信息

Department of Gastroenterology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.

出版信息

Hepatogastroenterology. 2013 May;60(123):481-8. doi: 10.5754/hge12003.

DOI:10.5754/hge12003
PMID:23635440
Abstract

BACKGROUND/AIMS: To compare the performance of the Child-Turcotte-Pugh (CTP), the Okuda, the Cancer of Liver Italian Program (CLIP), the Barcelona Clinic Liver Cancer (BCLC), the Chinese staging (CS), Chinese university prognostic index (CUPI), Japan integrated staging (JIS), the Tokyo and the French staging systems, in predicting the survival of patients with primary liver cancer (PLC) receiving transarterial chemoembolization (TACE).

METHODOLOGY

The clinical data of patients undergoing TACE in our department were retrospectively analyzed and compared with the 9 staging systems based on survival after TACE.

RESULTS

A cohort of 60 patients was involved. The survival curves showed that Okuda, BCLC, CS and JIS had better discriminatory ability. By the Cox regression model, Okuda, CS and JIS showed a stronger significance on prognosis. The staging systems with smaller value of -2Ln(L), Akaike Information criterion (AIC) and Schwarz-Bayesian criterion (SBC) were CS, JIS, CLIP and BCLC. An analysis involving 11 factors by Cox model indicated that ascites and vascular invasion were independent prognostic factors.

CONCLUSIONS

JIS provides better prognostic stratification for a cohort of the patients with PLC receiving TACE. However, studies with larger samples are still required.

摘要

背景/目的:比较Child-Turcotte-Pugh(CTP)、奥田、意大利肝癌项目(CLIP)、巴塞罗那临床肝癌(BCLC)、中国分期(CS)、中国大学预后指数(CUPI)、日本综合分期(JIS)、东京和法国分期系统在预测接受经动脉化疗栓塞术(TACE)的原发性肝癌(PLC)患者生存情况方面的表现。

方法

对在我科接受TACE治疗的患者的临床资料进行回顾性分析,并与基于TACE术后生存情况的9种分期系统进行比较。

结果

纳入了60例患者。生存曲线显示奥田、BCLC、CS和JIS具有更好的区分能力。通过Cox回归模型,奥田、CS和JIS对预后显示出更强的显著性。-2Ln(L)值、赤池信息准则(AIC)和施瓦茨贝叶斯准则(SBC)较小的分期系统为CS、JIS、CLIP和BCLC。通过Cox模型对11个因素进行分析表明,腹水和血管侵犯是独立的预后因素。

结论

JIS为接受TACE治疗的PLC患者队列提供了更好的预后分层。然而,仍需要更大样本量的研究。

相似文献

1
Prognostic accuracy of staging systems in patients with primary liver cancer undergoing transarterial chemoembolization.经动脉化疗栓塞术治疗的原发性肝癌患者分期系统的预后准确性
Hepatogastroenterology. 2013 May;60(123):481-8. doi: 10.5754/hge12003.
2
A new prognostic model for hepatocellular carcinoma based on total tumor volume: the Taipei Integrated Scoring System.基于总肿瘤体积的肝细胞癌新预后模型:台北综合评分系统。
J Hepatol. 2010 Jul;53(1):108-17. doi: 10.1016/j.jhep.2010.01.038. Epub 2010 Mar 31.
3
Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score.经动脉化疗栓塞治疗肝细胞癌:慕尼黑-TACE评分的开发与外部验证
Eur J Gastroenterol Hepatol. 2018 Jan;30(1):44-53. doi: 10.1097/MEG.0000000000001005.
4
Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.选择接受经动脉化疗栓塞术的肝细胞癌患者的预后替代肾指标。
J Gastroenterol Hepatol. 2012 Oct;27(10):1581-8. doi: 10.1111/j.1440-1746.2012.07151.x.
5
Prospective validation of the Barcelona Clinic Liver Cancer staging system.巴塞罗那临床肝癌分期系统的前瞻性验证
J Hepatol. 2006 Apr;44(4):723-31. doi: 10.1016/j.jhep.2005.12.015. Epub 2006 Jan 24.
6
Selecting an optimal staging system for hepatocellular carcinoma: comparison of 5 currently used prognostic models.选择最优的肝细胞癌分期系统:比较目前使用的 5 种预后模型。
Cancer. 2010 Jun 15;116(12):3006-14. doi: 10.1002/cncr.25044.
7
Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization.炎症评分可预测经动脉化疗栓塞术后乙型肝炎病毒相关肝细胞癌患者的生存情况。
World J Gastroenterol. 2015 May 14;21(18):5582-90. doi: 10.3748/wjg.v21.i18.5582.
8
Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.CLIP、奥田、TNM和JIS分期系统对接受手术的肝细胞癌患者的预测价值评估。
J Gastroenterol Hepatol. 2005 May;20(5):765-71. doi: 10.1111/j.1440-1746.2005.03746.x.
9
Validation of three staging systems for hepatocellular carcinoma (JIS score, biomarker-combined JIS score and BCLC system) in 4,649 cases from a Japanese nationwide survey.对来自日本全国性调查的4649例病例的三种肝细胞癌分期系统(JIS评分、生物标志物联合JIS评分和BCLC系统)进行验证。
Dig Dis. 2014;32(6):717-24. doi: 10.1159/000368008. Epub 2014 Oct 29.
10
[Evaluation of predictive value of Okuda, TNM, CLIP and JIS staging systems for hepatocellular carcinoma patients].[对奥田、TNM、CLIP和JIS分期系统对肝细胞癌患者预测价值的评估]
Korean J Hepatol. 2007 Jun;13(2):196-207.

引用本文的文献

1
A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors.基于淋巴结比率的分期模型优于目前的胰腺神经内分泌肿瘤分期系统。
J Clin Endocrinol Metab. 2018 Jan 1;103(1):187-195. doi: 10.1210/jc.2017-01791.
2
Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.在实际临床中采用传统经动脉化疗栓塞术治疗肝细胞癌:血清钠水平可预测生存期。
World J Gastroenterol. 2014 Jul 7;20(25):8158-65. doi: 10.3748/wjg.v20.i25.8158.